Azithromycin Exposure in a 10-Day Window of Myocardial Infarction and Short- and Long-Term Outcomes

Background: The U.S. Food and Drug Administration warned in 2012 that azithromycin (AZM) can cause potentially fatal irregular heart rhythm, particularly in patients with known cardiac risk factors. Objectives: This study aimed to examine cardiac and hospital readmission outcomes associated with AZM...

Full description

Bibliographic Details
Published in:JACC: Advances
Main Authors: Amanda Gusovsky, PhD, MPH, Emily Slade, PhD, Jasmine M. Forrest, PharmD, Darren Henderson, BS, Ahmed Abdel-Latif, MD, PhD, Vincent J. Venditto, PhD, Chris Delcher, PhD, David J. Feola, PhD, PharmD
Format: Article
Language:English
Published: Elsevier 2024-11-01
Subjects:
azithromycin
myocardial infarction
outcomes
secondary data
Online Access:http://www.sciencedirect.com/science/article/pii/S2772963X24006173

Internet

http://www.sciencedirect.com/science/article/pii/S2772963X24006173

Similar Items